Home Blog Page 1904

Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development

In head-to-head non-human primate (NHP) studies, average observed half-life of ASC35 was approximately 14 days, 6-fold longer than tirzepatide, which supports once-monthly subcutaneous (SQ) dosing in humans.

In head-to-head NHP studies, drug exposures of ASC35 intravenous (I.V.) and SQ administration were approximately 80% and 70% greater than tirzepatide I.V. and SQ administration, respectively.

ASC35 was approximately 4-fold more potent than tirzepatide for both GLP-1 receptor (GLP-1R) and GIP receptor (GIPR) in vitro.

ASC35 demonstrated approximately 71% greater relative body weight reduction compared to tirzepatide in a head-to-head diet-induced obese (DIO) mouse study.

Submission of an Investigational New Drug Application (IND) for ASC35 to the U.S. Food and Drug Administration (FDA) is expected in the second quarter of 2026.

HONG KONG, Oct. 13, 2025 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces that it has selected ASC35, a once-monthly, potentially best-in-class subcutaneously administered GLP-1 receptor (GLP-1R)/GIP receptor (GIPR) dual peptide agonist, as a clinical development candidate. Ascletis expects to submit an Investigational New Drug Application (IND) for ASC35 for the treatment of obesity to the U.S. Food and Drug Administration (FDA) in the second quarter of 2026.

ASC35, a GLP-1R and GIPR dual peptide agonist, was discovered and developed in-house utilizing Ascletis’ Artificial Intelligence-Assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies. ASC35 was approximately 4-fold more potent than tirzepatide for both GLP-1R and GIPR in vitro. ASC35 is engineered for a longer observed half-life (as measured by time to 50% Cmax) and higher bioavailability per milligram of peptide, compared to once-weekly administered tirzepatide, to support once-monthly SQ dosing, with injection volume of one milliliter or less. These engineered properties also allow for scalability advantages in manufacturing. 

In head-to-head non-human primate (NHP) studies, ASC35 slow-release SQ depot formulations had an average observed half-life of approximately 14 days, 6-fold longer than tirzepatide in its FDA-authorized SQ formulation. In head-to-head NHP studies, drug exposures (as measured by the area under curve) of ASC35 intravenous (I.V.) and SQ administration were approximately 80% and 70% greater than tirzepatide I.V. and SQ administration, respectively. The pharmacokinetic relationship between NHPs and humans is well established by multiple peptide agonists. For example, tirzepatide’s 56-hour half-life in NHPs translates into a half-life of 128 hours (5.3 days) in humans[1]. Therefore, the observed half-life of ASC35 in humans may be predicted to be 30 days or longer based on NHP studies. These preclinical data support ASC35 as a once-monthly treatment for obesity in humans. The longer observed half-life and a flatter pharmacokinetic profile of ASC35 in NHPs compared to other peptide incretins may also translate into a better gastrointestinal tolerability in humans. 

In a head-to-head diet-induced obese (DIO) mouse study, which is well established as being highly predictive of human efficacy, dosed with equal molar concentrations of ASC35 and tirzepatide, ASC35 reduced body weight by 33.6%, compared to 19.6% for tirzepatide, a relative increase in efficacy of 71% (Table 1). This superior weight loss per milligram of peptide may also provide scalability advantages in manufacturing.

Table 1. ASC35 demonstrated statistically and significantly more weight loss than tirzepatide in DIO mice

Group

Dosing

Total body weight change from baseline

Greater relative weight loss versus tirzepatide

Obese mice treated with vehicle

Vehicle,

SQ, QD

0.4 %

Obese mice treated with ASC35

3 nmol/kg,

SQ, QD

-33.6%

(p <0.0001 vs vehicle)

71%

(p <0.0001 vs tirzepatide)

Obese mice treated with tirzepatide

3 nmol/kg,

SQ, QD

-19.6%

(p <0.0001 vs vehicle)

Note: Treatment duration: 14 days; DIO mice/Obese mice: diet-induced obese mice; SQ: subcutaneous; QD: once daily. 

ASC35’s superior in vitro potency, longer observed half-life, better SQ bioavailability and greater weight loss compared to tirzepatide demonstrate its potential as a best-in-class treatment for obesity.

“The selection of our first peptide agonist for clinical development demonstrates our commitment to innovation and complements our portfolio of small molecule candidates for the treatment of obesity and other metabolic diseases,” said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis, “The preclinical characterization of ASC35 suggests best-in-class efficacy with once-monthly dosing resulting in superior weight loss and a more versatile and patient friendly titration schedule.”

Potential Combination Studies with ASC35

ASC35 is being developed as a monotherapy and in combination for the treatment of cardio-metabolic diseases including obesity, diabetes and metabolic dysfunction-associated steatohepatitis (MASH). Ascletis plans to combine ASC35, a GLP-1R/GIPR dual agonist, with its ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist to treat obesity and diabetes. Ascletis also plans to combine ASC35 with its once-monthly SQ ASC47, an adipose-targeted thyroid hormone receptor beta (THRβ) agonist, to treat multiple metabolic diseases such as obesity and MASH.

Ascletis’ AISBDD and ULAP technologies enable the Company to design, optimize and develop multiple once-monthly SQ ultra-long-acting peptides, including ASC35 and ASC36. Based on the properties of peptides, the Company can design, through its proprietary ULAP technology, various slow-release constants (k) for peptides in SQ depots to precisely release injected peptides over desired dosing intervals to reduce peak-to-trough ratios and improve clinical outcomes.

[1] Jennifer A Martin et al, Absorption, distribution, metabolism, and excretion of tirzepatide in humans, rats, and monkeys, European Journal of Pharmaceutical Sciences 202 (2024) 106895, https://doi.org/10.1016/j.ejps.2024.106895

About Ascletis Pharma Inc.

Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases. Utilizing its proprietary Artificial Intelligence-Assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies, Ascletis has developed multiple drug candidates in-house, including its lead program, ASC30, a small molecule GLP-1R agonist designed to be administered once daily orally and once monthly to once quarterly subcutaneously as a treatment therapy and a maintenance therapy for chronic weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK).

For more information, please visit www.ascletis.com.

Contact:

Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
Peter.vozzo@icrhealthcare.com

Ascletis Pharma Inc. PR and IR teams
+86-181-0650-9129 (China)
pr@ascletis.com
ir@ascletis.com

Verkada Appoints Leadership in Korea Amid Rising Demand for Cloud-Based Security

Edward Kim Joins as Country Manager to Lead Market Expansion and Regional Operations

SAN MATEO, Calif., Oct. 13, 2025 /PRNewswire/ — Verkada, a leader in AI-powered physical security technology, today announced the appointment of Edward Kim as Country Manager for Korea. In this role, Kim will lead Verkada’s go-to-market strategy, sales operations, and country expansion efforts as the company deepens its commitment to one of Asia’s most dynamic enterprise technology markets.

Edward Kim, Country Manager for Korea, Verkada
Edward Kim, Country Manager for Korea, Verkada

“Korea represents a significant growth opportunity for Verkada as organizations across the country seek modern, AI solutions to enhance their physical security infrastructure,” said Jonathon Dixon, Vice President and Managing Director of JAPAC. “Edward’s exceptional track record of building high-growth businesses and his deep expertise in the Korean enterprise market make him the ideal leader to accelerate our momentum in the region.”

Kim brings more than 25 years of enterprise technology experience spanning sales leadership, channel management, consulting, and engineering. Most recently, he served as Country Manager for Veeam Software Korea, where he delivered exceptional results, making Korea one of Veeam’s top-performing countries consistently over a four-year period. Under his leadership, Veeam Korea expanded from a handful of initial customers to more than 1,300 installations, establishing the company as a leading data management solution provider in the region.

Prior to Veeam, Kim led the managed service business for Fortinet Korea, collaborating closely with major telecommunications companies. He previously held roles with global IT companies including EMC, Commvault, and Sun Microsystems, building extensive relationships across Korea’s technology ecosystem.

“Korean organizations are rapidly adopting AI technologies, and security should be no exception,” said Edward Kim, Country Manager, Korea, at Verkada. “With Verkada’s platform, we have an opportunity to help schools, hospitals, and businesses protect what matters most with solutions that are modern, scalable, and easy to use.”

Kim’s appointment comes as Verkada continues to expand its presence across the Asia-Pacific region. The company’s customer base in the region has grown by 60% over the past year, with the support of strategic partnerships with leading local organizations, including SK Shieldus, LG CNS, and LS Sauter.

About Verkada
Designed with simplicity in mind, Verkada’s six product lines — video security cameras, access control, environmental sensors, alarms, workplace, and intercoms — provide unparalleled building security through an integrated, cloud-based software platform. Over 33,000 organizations across 93 countries worldwide, including 96 of the Fortune 500, trust Verkada as their physical security layer for easier management, intelligent control, and scalable deployments. For more information, please visit www.verkada.com.

Photo – https://laotiantimes.com/wp-content/uploads/2025/10/vkd_headshot.jpg
Logo – https://laotiantimes.com/wp-content/uploads/2025/10/image0_id_16ac0026ee69_logo.jpg

Reach Surgical’s OMNIBOT Performs First Urology Robotic Telesurgeries in Latin America

Advancing regional collaboration and surgeon training in remote robotic-assisted surgery

SINGAPORE, Oct. 13, 2025 /PRNewswire/ — Reach Surgical, the Surgical Solutions division of Genesis MedTech, has facilitated the completion of two robotic telesurgeries using its OMNIBOT robotic-assisted system.

Operating from Reach Surgical Institute (RSI) in Santiago, Dr. Roberto Vilches and Dr. Marcelo Kerkebe remotely performed a radical prostatectomy and a partial nephrectomy on patients at Meds Medical Center. These procedures mark an important milestone in advancing robotic telesurgery across Latin America. 

Expanding Access to Telesurgery
OMNIBOT’s first telesurgeries demonstrated both precision and performance. The procedures highlight the growing potential of remote robotic-assisted procedures and reinforce Reach Surgical’s long-term strategic focus on regional collaboration for telesurgery, developing new approaches to training and building strong partnerships with teaching hospitals.

RSI Training Facility and Collaboration with Hospitals
The RSI training facility in Santiago has developed a comprehensive training program for robotic surgery. This includes:
-Advanced simulation-based training
-Live surgical demonstrations and broadcasts
-Cross-regional telesurgery collaboration

By equipping surgeons with hands-on experience and expert guidance, this initiative is helping accelerate the adoption of robotic-assisted surgery in hospitals. 

Building on this milestone, Reach Surgical will continue to strengthen partnerships between RSI and regional medical institutions across Latin America.  The company remains focused on expanding the adoption of robotic telesurgery and supporting surgeon training and education, advancing minimally invasive surgery to make it more precise and within reach of more patients.

Regulatory Notice: OMNIBOT is subject to local regulatory approvals.

About Genesis MedTech Group
Genesis MedTech Group is a global medical device company headquartered in Singapore, dedicated to Making Better Healthcare Happen. We design and develop innovations that make treatments safer, less invasive and more accessible at scale, supporting healthcare providers in achieving improved patient outcomes and ensuring more patients benefit from medical advances. With integrated capabilities from R&D and manufacturing to commercialisation, Genesis MedTech builds on a strong foundation of quality, training and education – delivering high-quality medical devices across surgical, cardiology, and vascular interventional specialties.

Reach Surgical, the surgical solutions division of Genesis MedTech, provides a comprehensive surgical portfolio designed to support surgeons and advance surgical care. We are dedicated to developing reliable, high-quality solutions that address the evolving needs of surgical practice. For updates on surgical solutions, follow Reach Surgical on LinkedIn.

Learn more at https://www.genesismedtech.com and follow us on LinkedIn

Writing a new chapter in global women’s development

BEIJING, Oct. 13, 2025 /PRNewswire/ — A report from People’s Daily: The Global Leaders’ Meeting on Women will be held in Beijing from Oct. 13 to 14. This year marks the 30th anniversary of the Fourth World Conference on Women held in Beijing. The international community views this gathering as an opportunity to uphold true multilateralism, pursue development-oriented cooperation, and accelerate the implementation of the Beijing Declaration and the Platform for Action as well as the 2030 Agenda for Sustainable Development. The meeting is expected to make tangible progress in safeguarding and advancing women’s rights, setting a new milestone in the global cause of women’s development.

Remarkable progress of Chinese women

Chinese women are achieving unprecedented success. According to a recent article published on the website of Brazil’s Forum magazine, public policies, legal reforms, and social initiatives in recent years have profoundly transformed the lives of Chinese women in education, healthcare, employment, and political participation, reflecting China’s remarkable progress in advancing women’s development.

Since the beginning of the new era, China has pursued comprehensive development of endeavors concerning women. The living standards and overall well-being of women have risen significantly, with the country leading globally in poverty alleviation, education, science, and healthcare.

China has achieved a significant milestone: 690 million women now share in the nation’s moderately prosperous society. Females account for more than half of all students in higher education, 45.8 percent of sci-tech researchers, over half of entrepreneurs in the internet sector, and 42.3 percent of judges nationwide. Their average life expectancy exceeds 80 years, and the World Health Organization ranks China among the world’s top 10 performers in maternal and child health outcomes. Sima Bahous, UN Under-Secretary General and UN Women Executive Director, commended China’s remarkable achievements in gender equality and women’s empowerment, expressing hope that China will share more of its valuable experience with the world.

China’s commitment to global cooperation

China actively advances the global women’s agenda through collaborative international engagement. The country champions multilateral frameworks, leading regional and global initiatives for women’s development. China upholds the UN’ central role and fulfills its obligations under international conventions such as the Convention on the Elimination of All Forms of Discrimination Against Women.

Through sustained cooperation with UN agencies on gender equality, China has institutionalized women’s issues within global governance platforms. Since 2012, China has convened nearly 30 ministerial-level women’s conferences through major multilateral forums including APEC, G20, BRICS, and the Shanghai Cooperation Organization.

A landmark achievement came in 2015 with the establishment of the UNESCO Prize for Girls’ and Women’s Education – a China-UNESCO joint initiative. To date, this award has honored 20 organizations and projects worldwide. In Tanzania, the prize has helped girls at risk of dropping out return to school; in Costa Rica, digital skills training has empowered women to access new opportunities.

Empowering women through action

China mobilizes resources and implements practical initiatives to advance women’s empowerment in developing countries, significantly improving livelihoods. Through targeted public welfare programs addressing women and children’s health, education, and water security, hundreds of millions of women globally have seen tangible improvements in quality of life.

China has carried out women-focused projects worth $40 million across more than 20 countries, and organized over 100 training sessions for women and children from the Global South. The Luban Workshop, a Chinese vocational training program, has trained 5,499 female students, helping them embark on new career paths.

In Fiji, local woman Seruwaia Kabukabu transformed her community through Juncao cultivation, emerging as a local leader while driving shared prosperity. This poverty-alleviation model has earned the moniker “grass of happiness” across developing economies.

China actively shares its experience in advancing women’s development and supports efforts to enhance women’s status and participation across all sectors, helping address global challenges such as poverty, discrimination, and inequality.

The legacy of Zhang Guimei – principal of Yunnan’s Huaping Girls’ High School – has achieved global recognition. Her campaign educating thousands of impoverished mountain girls features prominently on UNESCO platforms and ranks among the most impactful “girls’ education” case studies worldwide.

Building a better future together

History has shown that there can be no liberation and progress for humanity without the liberation and progress of women. According to reports by UN Women and the UN Department of Economic and Social Affairs, closing the gender digital divide could benefit 343 million women and girls globally and lift 30 million people out of poverty by 2050. Yet more than 600 million women and girls still face conflict and instability, and 2 billion lack access to social security. Building a world free from gender discrimination and inclusive of all remains an urgent global mission.

Standing at a new historical starting point, China is ready to work hand in hand with all parties, take sustained and accelerated action, and make consistent efforts to advance global gender equality and women’s well-rounded development, thus jointly building a better world for all women, and for all humankind.

 

Osome Brings AI-Enabled Business Management Platform To UAE

  • AI simplifies business management for entrepreneurs
  • Businesses freed from admin to focus on growth
  • Osome to foster robust partner ecosystem

SINGAPORE and HONG KONG, Oct. 13, 2025 /PRNewswire/ — Osome, the AI-enabled business management platform trusted by over 30,000 entrepreneurs globally, has officially entered the United Arab Emirates (UAE) with the opening of its office in Dubai. This move underscores Osome’s commitment to alleviating financial and administrative burdens for founders while fostering a collaborative ecosystem of partners in the Middle East.

Osome Brings AI-Enabled Business Management Platform To UAE
Osome Brings AI-Enabled Business Management Platform To UAE

It is estimated that Dubai is home to over one million small and medium-sized enterprises (SMEs), but founders face increasing pressures to manage accounting, tax, and regulatory requirements as their businesses scale.

Helena Flores, Chief Operating Officer of Osome and Managing Director of Osome Dubai, states that the company aims to enable founders to focus more on their vision and less on financial administration through its AI-enabled business management platform, which is supported by accounting and tax professionals. Osome will also collaborate with partners across the UAE ecosystem to unlock new opportunities.

One of Osome’s customers is Aesty Labs, co-founded by Nadia Zueva (CEO) and Andrei Rychkov (CTO). Nadia said, “Partnering with Osome has transformed Aesty. Their AI-enabled platform has freed us from over 30 hours of monthly admin tasks, allowing us to focus on understanding our customers’ styles and helping them shop smarter. With clear visibility into our financials, we can drive growth and improve investor reporting.”

Osome provides accounting with unlimited bookkeeping, support for VAT and corporate tax, and compliance monitoring for statutory deadlines and financial statement requirements. 

Osome is engaging with the UAE ecosystem. It will participate in Expand North Star @ GITEX 2025 from 12 to 15 October 2025, to connect with potential collaborators and showcase its platform, while driving community-building activities for entrepreneurs and partners in Dubai.

In its other markets, Osome partners with digital solution providers, venture capitalists, and accelerators. These collaborations help founders access services that reduce costs, enhance efficiency, and accelerate growth. By implementing this model in Dubai, Osome aims to become an ecosystem enabler, continually seeking partners to add value for UAE entrepreneurs.

Helena said, “Osome’s expansion into the UAE positions us closer to a rapidly evolving ecosystem of global innovation. The UAE’s commitment to attracting talent, enhancing financial transparency, and digitising government processes aligns with our vision. As more entrepreneurs relocate to the region, our aim is to deliver efficient, tech-driven solutions to empower these founders in managing their businesses and financials transparently and productively.” 

About Osome

Osome provides an AI-enabled business management solution that combines intuitive digital tools with expert local guidance, helping entrepreneurs alleviate administrative burdens and focus on growth. Since 2017, it has supported over 30,000 companies with services in incorporation, accounting, tax, payroll, and corporate secretarial in Hong Kong, London, and Singapore. To date, Osome has processed over 5 million financial documents and generated more than 100,000 months of financial reporting. Visit www.osome.com for more information.

Axaipay and E3 Middle East Entrepreneur Network Sign MoU to Empower UAE Entrepreneurs Expanding into Malaysia and Australia

KUALA LUMPUR, Malaysia, Oct. 13, 2025 /PRNewswire/ — Axai Digital Sdn. Bhd. (“Axaipay”), a leading Malaysian fintech company, and E3 Middle East Entrepreneur Network LLC FZ (“E3HUBS”) have entered into a Memorandum of Understanding (MoU) during the Expand North Star 2025 event in Dubai, United Arab of Emirates (UAE). The collaboration aims to strengthen cross-border business collaboration and digital payment enablement for UAE-based entrepreneurs expanding into Malaysia and Australia.

(from Left to Right) Dr. Terry Yee, CEO of  Axaipay, Mr. Anuar Fariz Fadzil, CEO of MDEC and Ms. Suzaan, Managing Partner of E3HUBS UAE.
(from Left to Right) Dr. Terry Yee, CEO of Axaipay, Mr. Anuar Fariz Fadzil, CEO of MDEC and Ms. Suzaan, Managing Partner of E3HUBS UAE.

The signing ceremony was witnessed by Mr. Anuar Fariz Fadzil, Chief Executive Officer of the Malaysia Digital Economy Corporation (MDEC), and attended by His Excellency Tengku Sirajuzzaman Tengku Mohamed Ariffin, Ambassador of Malaysia to the United Arab Emirates, and Mr. Fahmy Ansara Dahalan, Chairman of the Malaysian Business Council UAE.

Representing the signatories were Dr. Terry Yee, Chief Executive Officer of Axaipay, and Ms. Suzaan Lim, Managing Partner of E3HUBS.

Under the MoU, Axaipay will serve as the Preferred Payment Partner within the E3HUBS ecosystem, offering secure and compliant payment gateway and merchant acquiring services to support seamless digital transactions in Malaysia and Australia.

E3HUBS will leverage its regional network to identify and nurture high-potential entrepreneurs, providing access to incubation, mentorship, and international market entry programs.

Together, both organizations aim to accelerate startup growth through:

  • Market Expansion Support: Streamlined merchant onboarding and payment acceptance for cross-border operations.
  • Training & Capacity Building: Joint workshops and mentorship covering payments, compliance, and e-commerce.
  • Program Integration: Embedding Axaipay’s digital payment expertise into E3HUBS programs such as LEAP, Chaos Leadership, and PowerGroups.
  • Innovation Pilots: Collaborative fintech projects focused on regional entrepreneurship development.

This partnership reinforces Axaipay’s commitment to driving financial inclusion and digital transformation in the ASEAN and MENA regions, while strengthening Malaysia’s role as a regional fintech hub.

“This partnership bridges Malaysia’s payment innovation with the UAE’s vibrant entrepreneurial ecosystem. Together, we aim to simplify cross-border commerce and enable startups to scale confidently,” said Dr. Terry Yee, CEO of Axaipay.

“This collaboration reflects our shared mission to connect entrepreneurs across borders with the tools, mentorship, and financial technology they need to grow. Through Axaipay’s innovation and E3HUBS’ ecosystem, we are enabling UAE startups to confidently expand into Malaysia and Australia,,” added Suzaan Lim, Managing Partner of E3HUBS.

About Axai Digital Sdn Bhd (or Axaipay)

Axaipay is a Malaysia-based fintech company and licensed payment service provider that enables businesses to accept online payments securely across Malaysia and Australia. Its comprehensive payment solutions support credit and debit cards, online banking, e-wallets, QR payments, and Buy Now Pay Later (BNPL) schemes. Axaipay empowers enterprises worldwide with innovative and reliable digital payment technologies, offering scalable white-label solutions that drive growth in both local and global e-commerce markets. For more information, visit www.axaipay.com

About E3 Middle East Entrepreneur Network LLC FZ (E3HUBS)

E3 Middle East Entrepreneur Network LLC FZ (E3HUBS) is a UAE-based startup ecosystem builder dedicated to empowering entrepreneurs through incubation, mentoring, and market access programs across Asia and the Middle East. For more information, visit www.e3hubs.com

 

MAGNET’25 SET TO BE THE BIGGEST INTERNATIONAL STUDENT GATHERING IN MALAYSIA FOR 2025

MALACCA CITY, Malaysia, Oct. 12, 2025 /PRNewswire/ — The Ministry of Higher Education (MoHE) and Universiti Teknikal Malaysia Melaka (UTeM), in collaboration with Education Malaysia Global Services (EMGS), will be organising the Meet and Greet with International Students in Malaysia 2025 (MAGNET’25).  This is a yearly event by the Ministry of Higher Education to gather International Students and institutions,  aims to be one of the largest international student gatherings ever held in Malaysia.

MAGNET 2025
MAGNET 2025

This year, the event, taking place at Dataran Pahlawan, Melaka, is set to welcome over 1,000 international students from higher education institutions across the country, participating and putting their efforts together in activities to enrich their Study in Malaysia experience.

It aims to celebrate Malaysia’s multicultural diversity and foster meaningful connections among the international student community. The event will also feature the launch of the Malaysia Edutourism Gateway (MEG) portal, which will be graced by YB Dato’ Seri Diraja Dr. Zambry Abd Kadir, Minister of Higher Education Malaysia.

MAGNET’25 will showcase a variety of engaging programmes, including a Heritage Trail, more than 20 country concept booths by participating universities, cultural performances, and interactive activities that highlight Malaysia’s vibrant culture and inclusive environment. Visitors can also look forward to fun experiences such as the Malaysia Edutourism booth, Batik canting, and the Study in Malaysia Student Ambassador interview sessions. The event is open to the public, inviting everyone to join in the excitement, with exciting activities and lucky draw prizes awaiting participants.

Through initiatives such as MAGNET’25, Malaysia continues to strengthen its position as a global education hub, in line with its aspiration to become the preferred education destination among international students around the world.

EDUCATION MALAYSIA GLOBAL SERVICES (EMGS)
14TH OCTOBER 2025

About Education Malaysia Global Services (EMGS)

Education Malaysia Global Services (EMGS) is a Company Limited by Guarantee (“CLBG”) under the purview of the Ministry of Higher Education Malaysia. EMGS is the wing responsible for promoting Malaysia as the talent and knowledge hub and the preferred education destination among international students around the world. It is also the principal body that manages the movement of international students in Malaysia, including facilitating visa processing.

SCAN THE QR CODE TO FOLLOW EMGS


 

Where Light Meets Shadow, Beauty Unveiled- Review of the 2nd Golden Panda Awards

CHENGDU, China, Oct. 12, 2025 /PRNewswire/ — In the golden September, in the homeland of pandas, the feast of light and shadow commenced once again, as the cultural rendezvous arrived as scheduled.


On September 12th and 13th, the 2nd Golden Panda Awards were grandly held in Chengdu. Organized by the China Federation of Literary and Art Circles and the People’s Government of Sichuan Province, and permanently hosted in Sichuan, the Golden Panda Awards consistently uphold the purpose of “promoting the building of a community with a shared future for mankind.” They are dedicated to fostering mutual learning among civilizations and promoting the common values of all humanity by selecting outstanding global film and television productions and organizing cultural exchange activities.

The awards cover four major categories: film, TV drama, documentary, and animation. Their professionalism, authority, international reach, and innovation have garnered widespread participation and attention from global film institutions and creators. The diverse and rich events of this year’s Golden Panda Awards facilitated dialogue and integration among human civilizations. The 27 awards presented demonstrated exceptionally high artistic standards, humanistic value, and innovative breakthroughs.

Under the theme “Where Light Meets Shadow, Beauty Unveiled”, the 2nd Golden Panda Awards, leveraging the universal language of film and television, actively participated in shaping the new global landscape of arts. With an open and inclusive stance, it conveyed the cultural confidence of a thriving Chinese modernization, allowing different civilizations to illuminate each other through dialogue.